Nutex Health Inc (NUTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 145,558 | -7,117 | -950 | 582 | -7,432 |
| Depreciation Amortization | 5,898 | 172 | 3 | 535 | 1 |
| Accounts receivable | -71,235 | 112 | -82 | -4 | N/A |
| Accounts payable and accrued liabilities | 6,231 | N/A | N/A | N/A | N/A |
| Other Working Capital | -66,024 | -74 | 311 | 194 | 307 |
| Other Operating Activity | 66,243 | 2,866 | 238 | -2,021 | 6,851 |
| Operating Cash Flow | $86,672 | $-4,041 | $-480 | $-715 | $-274 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61,189 | -84 | N/A | N/A | N/A |
| Net Acquisitions | N/A | -564 | -117 | 30 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -15 |
| Other Investing Activity | 0 | -100 | 0 | -28 | 5 |
| Investing Cash Flow | $-61,189 | $-748 | $-117 | $2 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 58,173 | 2,360 | 916 | 469 | 50 |
| Debt Repayment | -16,908 | -737 | -212 | -9 | -2 |
| Common Stock Issued | N/A | 4,113 | N/A | 275 | N/A |
| Dividend Paid | -59,051 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 9,813 | 0 | 0 | -24 | 124 |
| Financing Cash Flow | $-7,973 | $5,735 | $705 | $712 | $172 |
| Beginning Cash Position | 8,004 | 119 | 12 | 11 | 122 |
| End Cash Position | 25,514 | 1,065 | 119 | 9 | 11 |
| Net Cash Flow | $17,510 | $946 | $108 | $-1 | $-112 |
| Free Cash Flow | |||||
| Operating Cash Flow | 86,672 | -4,041 | -480 | -715 | -274 |
| Capital Expenditure | -61,189 | -84 | N/A | N/A | N/A |
| Free Cash Flow | 25,483 | -4,125 | -480 | -715 | -274 |